| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |